Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

570.05INR
22 May 2019
Change (% chg)

-- (--)
Prev Close
Rs570.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
602,246
52-wk High
Rs711.90
52-wk Low
Rs505.50

Tempest, Brian 

Dr. Brian William Tempest serves as Non-Executive Independent Director of Glenmark Pharmaceuticals Ltd. Dr. Tempest has been working with the pharmaceutical industry for the last four decades and has managed healthcare businesses in North America, South America, Europe, Africa, the Middle East, Australasia, China, Japan and India. He is the editor of the Journal of Generic Medicines. He is also a Non-Executive Director on the Governance Board of the United Nations Patent Pool.

Basic Compensation

Total Annual Compensation, INR 400,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018